BioSpace News Archive

DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been clearedto treat pain following a Caesarean-section (C-section).

PatientBond, announced today that it has contracted with Vizient, Inc., the largest member-driven health care performance improvement company in the country, to offer digital patient engagement and behavior change programs to Vizient member healthcare organizations for improved clinical and business outcomes.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool (MPP) today announced the signing of a new voluntary licensing agreement for patents relating to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) to help enable access in least developed, low-income, lower middle-income and Sub-Saharan African countries.

The latest market analysis report published by Reports and Data, titled ‘Global Overactive Bladder Market – Forecast to 2030,’ thoroughly examines the Overactive Bladder industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Meibomian Gland Dysfunction Market – Forecast to 2030,’ thoroughly examines the Meibomian Gland Dysfunction industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Iron-Deficiency Anemia Treatment Market – Forecast to 2030,’ thoroughly examines the Iron-Deficiency Anemia Treatment industry to provide essential data & information for the targeted readers.

Gilead Sciences, Inc. announced results reinforcing Biktarvy® as a highly efficacious treatment option for a broad range of people with HIV, including individuals with HIV/hepatitis B coinfection.

According to the most recent analysis by Emergen Research, the worldwide regenerative medicine market size reached USD 9.80 billion in 2021 and is anticipated to grow at a revenue CAGR of 15.9% over the projected period.

According to the Report Study, the interventional pulmonology market size was valued at US$ 3 Bn in 2020 and is expected to reach US$ 8 billion by 2030, expanding growth at a CAGR of 9.1% from 2021 to 2030.

American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point in its HIV cure clinical trial: it began withdrawing participants from their antiretroviral drugs earlier this month.